Latest filing published 21 Nov 2018 for Aimmune Therapeutics, Inc., €106k.
Filing timeline
BuySaleInsider track record
Susan E. Barrowcliffe: trading record in brief
All filings by Susan E. Barrowcliffe on record concern Aimmune Therapeutics, Inc. Over a trading history stretching from 8 November 2016 to 19 November 2018, the count stands at 30 filings.
The open-market record consists of 17 sales worth €5.3M, with no purchase. Besides market trades, the filings include 1 share grant and 12 option exercises. So far in 2018, the count stands at no purchases and 7 sales.
The newest entry dates from 21 November 2018: an option exercise of €106k, in Aimmune Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Susan E. Barrowcliffe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 40,000 shares@ US$3.022.9% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-029542:0
- 40,000 shares@ US$30.0428.7% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-029542:1
- 9,375 shares0Common Stock, $0.0001 par valueSEC:0000899243-18-006569:0
- 75,000 shares@ US$3.023.3% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-000454:0
- 24,401 shares@ US$37.1213.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-000454:1
- 599 shares@ US$37.780.3% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-000454:2
- 24,700 shares@ US$37.1313.2% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-000454:3
- 300 shares@ US$37.860.2% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-000454:4
- 24,400 shares@ US$37.1213.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-000454:5
- 600 shares@ US$37.750.3% of flowCommon Stock, $0.0001 par valueSEC:0000899243-18-000454:6
- 20,000 shares@ US$3.020.9% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-022643:0
- 20,000 shares@ US$25.007.3% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-022643:1
- 3,223 shares@ US$3.020.1% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-021595:0
- 3,223 shares@ US$22.001.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-021595:1
- 15,167 shares@ US$3.020.7% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-021595:2
- 15,167 shares@ US$22.004.8% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-021595:3
- 500 shares@ US$3.020.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-019355:0
- 500 shares@ US$22.000.2% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-019355:1
- 960 shares@ US$3.020.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-018926:0
- 960 shares@ US$22.000.3% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-018926:1
- 500 shares@ US$3.020.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-018926:2
- 500 shares@ US$22.000.2% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-018926:3
- 4,650 shares@ US$3.020.2% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-018926:4
- 4,650 shares@ US$22.001.5% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-018926:5
- 15,000 shares@ US$3.020.7% of flowCommon Stock, $0.0001 par valueSEC:0000899243-17-017958:0
25 of 30 declarations
